Developer docs
API playgroundTry for free, no card

Search company profiles

Association of Biotechnology Led Enterprises

Full company profile

uuid00bqf4u

Namestring
Association of Biotechnology Led Enterprises
Legal namestring
Association of Biotechnology Led Enterprises
Websiteurl
ableindia.in
Company typeenum
Private
Founded yearint
2003
Descriptiontext

The Association of Biotechnology Led Enterprises (ABLE), founded in 2003 and headquartered in Bangalore, India, is a non-profit industry association that serves as the coordinating body for India's biotechnology sector, with particular focus on the Karnataka ecosystem. It represents biotechnology-led enterprises across biotech startups, biopharma, BioIndustrial, and BioServices segments, and operates as a convening platform between industry, academia, and government bodies including the Karnataka Innovation and Technology Society (KITS), BIRAC, and SIA-India. Rather than offering commercial products, ABLE generates its core deliverables through advocacy, ecosystem development, and the production of authoritative sector research — most notably the Karnataka BioEconomy Report (jointly with KITS) and the India Bioeconomy report (jointly with BIRAC) — which track bioeconomy size, startup counts, investment flows, and segment growth.

ABLE's revenue mechanics are characteristic of a membership-based industry body: member dues, industry events, and co-funded research collaborations, though no pricing or financial figures are publicly disclosed. Its go-to-market is structured around research publication, government partnerships, and industry events rather than traditional sales channels, and its distribution is oriented toward government stakeholders (KITS, BIRAC) and enterprise member companies within the regional Karnataka biotech network. Recent strategic activity includes the May 2026 MoU with the Centre of Excellence for Space Technology to extend its mandate into space-biotech crossover applications, and the 2025 partnership with KITS supporting the release of the Karnataka BioEconomy Report 2025. ABLE does not disclose headcount beyond a band of 11-50 employees, has no subsidiaries, no funding rounds, no M&A activity, and no app or API surface documented in the input.

The underlying market ABLE serves is substantial and growing: Karnataka's bioeconomy reached $39.2 billion in 2025 (10.51% of state GSDP), accounting for approximately 20.63% of India's national bioeconomy ($195.3B in 2025), supported by 1,451 biotech startups and $1.14 billion of investment across approximately 40 deals from January 2024 to October 2025.

Short descriptiontext

The Association of Biotechnology Led Enterprises (ABLE) is a non-profit industry association founded in 2003 in Bangalore, India, representing biotechnology-led enterprises through advocacy, ecosystem development, and authoritative bioeconomy research reports produced with state and national government partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBangalore, India
HQ citystring
Bangalore
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
biotechnology advocacy, industry association, bioeconomy research, biotech policy, ecosystem development
Industry1 code
1Global Health Research, Evidence & Technical Assistance Organizations
CodeHLAJAKANPrimaryYes
NAICS code1 code
  • Business Associations813910
SIC code1 code
  • Services-Membership Organizations8600
Product category
Biotechnology Industry Association
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Association of Biotechnology Led Enterprises (ABLE) is a non-profit industry association that supports India's biotechnology ecosystem through policy advocacy, networking, and industry programs. It collaborates with government agencies (such as Karnataka Innovation and Technology Society and BIRAC), research institutions, and industry partners to produce authoritative bioeconomy research reports, drive policy advocacy, and foster ecosystem development for biotechnology companies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Karnataka bioeconomy grew from $31B to $39.2B (26.5% growth) under ecosystem development efforts
+3 more records
Product overview1 text field

ABLE (Association of Biotechnology Led Enterprises) is an industry association representing biotechnology companies in India. Rather than offering a commercial product suite, ABLE serves as a coordinating body that collaborates with government agencies, research institutions, and industry partners on biotechnology ecosystem development initiatives, policy advocacy, and economic reporting. The association contributes to bioeconomy research and reports rather than operating product lines.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1CoE SpaceTech Foundation
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-05-01
Description

Association of Biotechnology Led Enterprises signed strategic MoU with the Centre of Excellence for Space Technology (CoE SpaceTech Foundation) established by Karnataka Innovation and Technology Society in collaboration with SIA-India. The partnership aims to support advanced research, industry-aligned training, startup incubation, and cross-sector applications bridging space technology with biotechnology applications.

thehindu.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-02-24
Description

Joint collaboration for producing the Karnataka BioEconomy Report, which tracks the state's bioeconomy growth, startup ecosystem, and investment trends. The partnership enables data-driven policy insights and positions Karnataka as India's leading biotech hub contributing approximately 21% of India's bioeconomy.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

ABLE publishes the India Bioeconomy report in collaboration with BIRAC, providing comprehensive data on India's biotechnology sector performance. BIRAC has enabled over Rs. 4,200 crore in funding support across more than 15 lakh startups and entrepreneurs, catalyzing Rs. 7,000 crore in total investment and supporting 900+ product developments.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

BIO is the largest biotechnology trade association globally, representing biotech companies, academic institutions, and related organizations across the US. Directly comparable to ABLE as an industry body that advocates for the biotech sector, produces authoritative sector data, and convenes stakeholders across industry, academia, and government.

TypeBroad incumbent
Description

NASSCOM is India's premier trade body for the IT and BPM industry, focused on sector advocacy, research reports, and ecosystem development. Comparable to ABLE in operating model (Indian trade association producing sector research and policy advocacy), though focused on IT rather than biotechnology.

TypeBroad incumbent
Description

CII is one of India's premier business associations representing industry across sectors including life sciences. Comparable to ABLE in its role as an Indian industry association advocating for member interests, though operating far more broadly across all industries rather than focusing specifically on biotechnology.

TypeBroad incumbent
Description

FICCI is one of the largest and oldest business chambers in India, representing industry across sectors. Comparable to ABLE as a high-influence Indian industry body engaged in policy advocacy and ecosystem development, though with a multi-sector mandate rather than biotech specialization.

TypeRegional player
Description

BIOTECanada is Canada's national biotechnology industry association representing biotech companies across health, agricultural, industrial, and environmental sectors. Directly comparable in mandate to ABLE but operating at a national level in Canada with international linkages.

TypeDirect peer
Description

EuropaBio is the European Association for Bioindustries, representing biotechnology companies and bodies across the EU. Directly comparable to ABLE in mission (biotech advocacy, policy engagement, sector data) though operating at a multi-country regional level rather than a single state.

TypeRegional player
Description

AusBiotech is Australia's national biotechnology industry association, focused on advocacy, sector development, and member services. Comparable to ABLE as a national-level biotech trade body, though operating in a different geography (Australia vs India).

TypeRegional player
Description

ABPI is the UK trade association for pharmaceutical companies, focused on policy advocacy, member services, and sector data. Comparable to ABLE as a national pharma/biotech industry association, though operating in the UK and with a primarily pharma (rather than broader biotech) focus.

TypeRegional player
Description

Pharmexcil is an Indian export promotion council for pharmaceuticals, established under the Ministry of Commerce. Comparable to ABLE as an Indian life sciences industry body focused on sector development, though specializing in pharma exports rather than broader biotech ecosystem support.

TypeRegional player
Description

France Biotech is the French association of life sciences entrepreneurs and investors, focused on biotech innovation and ecosystem development in France. Comparable to ABLE in mission to grow a national biotech ecosystem, though operating in France.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Association of Biotechnology Led Enterprises

Biotechnology Industry Associationableindia.in

The Association of Biotechnology Led Enterprises (ABLE) is a non-profit industry association founded in 2003 in Bangalore, India, representing biotechnology-led enterprises through advocacy, ecosystem development, and authoritative bioeconomy research reports produced with state and national government partners.

What Association of Biotechnology Led Enterprises does

The Association of Biotechnology Led Enterprises (ABLE), founded in 2003 and headquartered in Bangalore, India, is a non-profit industry association that serves as the coordinating body for India's biotechnology sector, with particular focus on the Karnataka ecosystem. It represents biotechnology-led enterprises across biotech startups, biopharma, BioIndustrial, and BioServices segments, and operates as a convening platform between industry, academia, and government bodies including the Karnataka Innovation and Technology Society (KITS), BIRAC, and SIA-India. Rather than offering commercial products, ABLE generates its core deliverables through advocacy, ecosystem development, and the production of authoritative sector research — most notably the Karnataka BioEconomy Report (jointly with KITS) and the India Bioeconomy report (jointly with BIRAC) — which track bioeconomy size, startup counts, investment flows, and segment growth.

ABLE's revenue mechanics are characteristic of a membership-based industry body: member dues, industry events, and co-funded research collaborations, though no pricing or financial figures are publicly disclosed. Its go-to-market is structured around research publication, government partnerships, and industry events rather than traditional sales channels, and its distribution is oriented toward government stakeholders (KITS, BIRAC) and enterprise member companies within the regional Karnataka biotech network. Recent strategic activity includes the May 2026 MoU with the Centre of Excellence for Space Technology to extend its mandate into space-biotech crossover applications, and the 2025 partnership with KITS supporting the release of the Karnataka BioEconomy Report 2025. ABLE does not disclose headcount beyond a band of 11-50 employees, has no subsidiaries, no funding rounds, no M&A activity, and no app or API surface documented in the input.

The underlying market ABLE serves is substantial and growing: Karnataka's bioeconomy reached $39.2 billion in 2025 (10.51% of state GSDP), accounting for approximately 20.63% of India's national bioeconomy ($195.3B in 2025), supported by 1,451 biotech startups and $1.14 billion of investment across approximately 40 deals from January 2024 to October 2025.

Association of Biotechnology Led Enterprises firmographics

Firmographics
Name
Association of Biotechnology Led Enterprises
Legal name
Association of Biotechnology Led Enterprises
Website
https://ableindia.in
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
11–50 employees
Short description
The Association of Biotechnology Led Enterprises (ABLE) is a non-profit industry association founded in 2003 in Bangalore, India, representing biotechnology-led enterprises through advocacy, ecosystem development, and authoritative bioeconomy research reports produced with state and national government partners.
Ownership category
akta.pro rank

Association of Biotechnology Led Enterprises industry classification

Industry
Product category
Biotechnology Industry Association
NAICS
Business Associations (813910)
SIC
Services-Membership Organizations (8600)
akta.pro primary industry
Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

Keywords

  • Biotechnology advocacy
  • Industry association
  • Bioeconomy research
  • Biotech policy
  • Ecosystem development

Where Association of Biotechnology Led Enterprises is headquartered

Location

Headquarters

HQ city
Bangalore
HQ country
India
HQ region
Asia

Markets served

Association of Biotechnology Led Enterprises business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Distribution channels2 records

Marketing channels3 records

Association of Biotechnology Led Enterprises product offering

Product offering

Core offering

Association of Biotechnology Led Enterprises (ABLE) is a non-profit industry association that supports India's biotechnology ecosystem through policy advocacy, networking, and industry programs. It collaborates with government agencies (such as Karnataka Innovation and Technology Society and BIRAC), research institutions, and industry partners to produce authoritative bioeconomy research reports, drive policy advocacy, and foster ecosystem development for biotechnology companies.

Product overview

ABLE (Association of Biotechnology Led Enterprises) is an industry association representing biotechnology companies in India. Rather than offering a commercial product suite, ABLE serves as a coordinating body that collaborates with government agencies, research institutions, and industry partners on biotechnology ecosystem development initiatives, policy advocacy, and economic reporting. The association contributes to bioeconomy research and reports rather than operating product lines.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • Karnataka bioeconomy grew from $31B to $39.2B (26.5% growth) under ecosystem development efforts
  • +3 more outcomes

Companies that use Association of Biotechnology Led Enterprises

Customer profile

Segments4 records

Ideal customer profiles3 records

Association of Biotechnology Led Enterprises technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Association of Biotechnology Led Enterprises partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered flagship and core.

  • CoE SpaceTech FoundationflagshipStrategic or Co-development Partner · 1 May 2026Association of Biotechnology Led Enterprises signed strategic MoU with the Centre of Excellence for Space Technology (CoE SpaceTech Foundation) established by Karnataka Innovation and Technology Society in collaboration with SIA-India. The partnership aims to support advanced research, industry-aligned training, startup incubation, and cross-sector applications bridging space technology with biotechnology applications.
  • Karnataka Innovation and Technology Society (KITS)coreStrategic or Co-development Partner · 24 February 2025Joint collaboration for producing the Karnataka BioEconomy Report, which tracks the state's bioeconomy growth, startup ecosystem, and investment trends. The partnership enables data-driven policy insights and positions Karnataka as India's leading biotech hub contributing approximately 21% of India's bioeconomy.
  • BIRAC (Biotechnology Industry Research Assistance Council)coreStrategic or Co-development PartnerABLE publishes the India Bioeconomy report in collaboration with BIRAC, providing comprehensive data on India's biotechnology sector performance. BIRAC has enabled over Rs. 4,200 crore in funding support across more than 15 lakh startups and entrepreneurs, catalyzing Rs. 7,000 crore in total investment and supporting 900+ product developments.

Scale indicators6 records

Recent moves4 records

Expansion highlights4 records

Association of Biotechnology Led Enterprises competitors and assessment

Company assessment

Direct peers

  • Biotechnology Innovation Organization (BIO): BIO is the largest biotechnology trade association globally, representing biotech companies, academic institutions, and related organizations across the US. Directly comparable to ABLE as an industry body that advocates for the biotech sector, produces authoritative sector data, and convenes stakeholders across industry, academia, and government.
  • EuropaBio: EuropaBio is the European Association for Bioindustries, representing biotechnology companies and bodies across the EU. Directly comparable to ABLE in mission (biotech advocacy, policy engagement, sector data) though operating at a multi-country regional level rather than a single state.

Broad incumbents

  • NASSCOM: NASSCOM is India's premier trade body for the IT and BPM industry, focused on sector advocacy, research reports, and ecosystem development. Comparable to ABLE in operating model (Indian trade association producing sector research and policy advocacy), though focused on IT rather than biotechnology.
  • Confederation of Indian Industry (CII): CII is one of India's premier business associations representing industry across sectors including life sciences. Comparable to ABLE in its role as an Indian industry association advocating for member interests, though operating far more broadly across all industries rather than focusing specifically on biotechnology.
  • Federation of Indian Chambers of Commerce & Industry (FICCI): FICCI is one of the largest and oldest business chambers in India, representing industry across sectors. Comparable to ABLE as a high-influence Indian industry body engaged in policy advocacy and ecosystem development, though with a multi-sector mandate rather than biotech specialization.

Regional players

  • BIOTECanada: BIOTECanada is Canada's national biotechnology industry association representing biotech companies across health, agricultural, industrial, and environmental sectors. Directly comparable in mandate to ABLE but operating at a national level in Canada with international linkages.
  • AusBiotech: AusBiotech is Australia's national biotechnology industry association, focused on advocacy, sector development, and member services. Comparable to ABLE as a national-level biotech trade body, though operating in a different geography (Australia vs India).
  • Association of the British Pharmaceutical Industry (ABPI): ABPI is the UK trade association for pharmaceutical companies, focused on policy advocacy, member services, and sector data. Comparable to ABLE as a national pharma/biotech industry association, though operating in the UK and with a primarily pharma (rather than broader biotech) focus.
  • Pharmaceuticals Export Promotion Council of India (Pharmexcil): Pharmexcil is an Indian export promotion council for pharmaceuticals, established under the Ministry of Commerce. Comparable to ABLE as an Indian life sciences industry body focused on sector development, though specializing in pharma exports rather than broader biotech ecosystem support.
  • France Biotech: France Biotech is the French association of life sciences entrepreneurs and investors, focused on biotech innovation and ecosystem development in France. Comparable to ABLE in mission to grow a national biotech ecosystem, though operating in France.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Association of Biotechnology Led Enterprises social profiles

Digital presence

Association of Biotechnology Led Enterprises financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Association of Biotechnology Led Enterprises leadership team

Management profile

Number of profiles

Association of Biotechnology Led Enterprises funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Association of Biotechnology Led Enterprises M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Association of Biotechnology Led Enterprises

What does Association of Biotechnology Led Enterprises do?

Association of Biotechnology Led Enterprises (ABLE) is a non-profit industry association that supports India's biotechnology ecosystem through policy advocacy, networking, and industry programs. It collaborates with government agencies (such as Karnataka Innovation and Technology Society and BIRAC), research institutions, and industry partners to produce authoritative bioeconomy research reports, drive policy advocacy, and foster ecosystem development for biotechnology companies.

Is Association of Biotechnology Led Enterprises a public or private company?

Association of Biotechnology Led Enterprises is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Association of Biotechnology Led Enterprises founded?

Association of Biotechnology Led Enterprises was founded in 2003. It employs 11 to 50 people.

Where is Association of Biotechnology Led Enterprises based?

Association of Biotechnology Led Enterprises is headquartered in Bangalore, India, in the Asia region.

Who are Association of Biotechnology Led Enterprises's main competitors?

Direct peers on record are Biotechnology Innovation Organization (BIO) and EuropaBio. Broad incumbents are NASSCOM, Confederation of Indian Industry (CII) and Federation of Indian Chambers of Commerce & Industry (FICCI). Regional players are BIOTECanada, AusBiotech, Association of the British Pharmaceutical Industry (ABPI), Pharmaceuticals Export Promotion Council of India (Pharmexcil) and France Biotech.

Does Association of Biotechnology Led Enterprises have an API?

No public API is recorded for Association of Biotechnology Led Enterprises.

What industry is Association of Biotechnology Led Enterprises in?

Association of Biotechnology Led Enterprises's product category is Biotechnology Industry Association. Its primary akta.pro industry code is HLAJAKAN, Global Health Research, Evidence & Technical Assistance Organizations. Its NAICS code is 813910 and its SIC code is 8600.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The HinduIndia’s first State-led Centre of Excellence for space tech launched in BengaluruKarnataka has launched India’s first State-led Centre of Excellence for Space Technology (CoE SpaceTech Foundation) in Bengaluru, established through the Karnataka Innovation and Technology Society in collaboration with SIA-India. The initiative aims to bridge the gap between R&D capability and market-ready solutions by supporting advanced research, industry-aligned training, start-up incubation, and cross-sector applications of space technologies. The centre has signed strategic MoUs with Manipal Academy of Higher Education, Helogen Corporation (U.S.), Association of Biotechnology Led Enterprises, Dassault Systèmes, and Idea Baaz to align offerings with industry needs.UsthadianSUJVIKA Portal Strengthens India Bioeconomy VisionThe Department of Biotechnology (DBT) launched the SUJVIKA portal, an AI-driven biotech product data platform developed in collaboration with the Association of Biotechnology Led Enterprises (ABLE), during its 40th Foundation Day celebrations. This initiative aims to provide structured import data and sector insights to support evidence-based policymaking and strengthen public-private partnerships in India's bioeconomy. The launch coincides with broader government efforts under the BioE3 Policy to accelerate innovation and achieve a $1 trillion bioeconomy by 2047.The Indian ExpressKarnataka’s bioeconomy hits $39bn, sector grows 26.5% in 2 years: ReportKarnataka's biotechnology ecosystem grew from $31.0 billion in 2023 to $39.2 billion in 2025, representing a cumulative rise of 26.5%, according to the Karnataka Bioeconomy Report released jointly by the Karnataka Innovation and Technology Society and the Association of Biotechnology Led Enterprises. The sector now accounts for approximately 10% of the state's Gross State Domestic Product, with pharma firms contributing around 40% of the bioeconomy's value at $16.44 billion. The report identified 1,451 biotech startups in the state, including 218 new startups added in 2025 alone, while noting structural priorities needed to scale biomanufacturing and bridge skill gaps.The HinduKarnataka contributes one-fifth to the national bioeconomy: ReportThe Karnataka BioEconomy Report 2025, prepared by the Association of Biotechnology-Led Enterprises for the Karnataka government, reveals the state's bioeconomy expanded from $31 billion to $39.2 billion between 2023 and 2025, representing a 26.5% cumulative growth and contributing over one-fifth (20.63%) to India's national bioeconomy. Karnataka's bioeconomy accounted for 10.51% of the state's GSDP in 2025, more than double the biotech sector's share of India's GDP, with biopharma anchoring over 40% of the sector while bioindustrial emerged as the fastest-growing segment. The state added 218 new biotech startups in 2025 and attracted $1.14 billion in investment across approximately 40 deals between January 2024 and October 2025.https://www.outlookbusiness.com/Karnataka's BioEconomy Reaches $39.2 Billion, Says Report – Outlook BusinessKarnataka's bioeconomy has reached $39.2 billion in 2025, representing 26.5% cumulative growth from $31.0 billion in 2023, according to the Karnataka BioEconomy Report 2025 released by the Karnataka Innovation and Technology Society in collaboration with the Association of Biotechnology Led Enterprises. The state contributes approximately 21% of India's bioeconomy and accounts for over 10% of its GSDP, with BioPharma remaining the anchor sector at over 40% share and BioIndustrial biotechnology emerging as the fastest-growing segment at around 29%. The report also noted that Karnataka attracted $1.14 billion across around 40 deals between January 2024 and October 2025, and added 218 new biotech startups in 2025, bringing the cumulative total to 1,451.The Times of IndiaSouth leads in bioeconomy boom with 45.4% share in 2024 - The Economic TimesSouth India accounted for $75.2 billion (45.4%) of India's estimated $165.7 billion bioeconomy in 2024, leading all regions, with Maharashtra, Karnataka, and Telangana emerging as the dominant biotech hubs collectively contributing 38.8% of the national total. The India Bioeconomy report published by the Association of Biotechnology Led Enterprises noted the sector has grown 16-fold over the past decade, though new biotech startup registrations fell 13% to 1,544 from 1,776 in 2023. Industry and government leaders emphasized that collaboration between industry, academia, and policymakers will be essential for India to achieve its ambition of becoming a global bio-industrial hub.Express PharmaG S Krishnan is the new President of ABLEG S Krishnan has assumed the role of President at the Association of Biotechnology-Led Enterprises (ABLE), succeeding Shrikumar Suryanarayan. He will lead a nine-member executive council elected for a three-year term starting April 1, 2021, with Kiran Mazumdar-Shaw continuing as honorary non-executive chairperson. Krishnan outlined strategic goals to expand India's bio-based economy to $150 billion by 2025, leveraging capabilities in biopharma and bio-agriculture.